Product Information

QUETIAPINE ER 400 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3080 per EA under NDC 33342013709. Its NADAC has been published 432 times since May 16, 2018.

FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE ER 400 MG TABLET

QUETIAPINE
$0.3080per EA

Strength

400 mg/1

NDC

33342013709

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204253

FDA Approved

11/29/2017

TE Code

AB

On Market Since

11/1/2017

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE ER 400 MG TABLET has been published 432 times since May 16, 2018, and over the history we have for it it has declined 65.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3080 per EA
All-time high$0.9277 (Jun 13, 2018)
All-time low$0.2506 (Jul 17, 2024)
52-week high$0.3390
52-week low$0.3021
Median price$0.4254
Average price$0.4740
Largest weekly change+47.1% (Aug 21, 2024)
Weeks tracked432
Tracking sinceMay 16, 2018

Price History

1W

-1.7%

1M

-1.7%

3M

-4.5%

6M

-9.1%

1Y

+0.8%

3Y

-35.3%

5Y

-42.0%

All

-65.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the QUETIAPINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of QUETIAPINE ER 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.3080 per EA (NDC 33342013709), effective Aug 19, 2026.

How has the price of QUETIAPINE ER 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 65.6%. It has been tracked across 432 weekly CMS publications since May 16, 2018.

What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?

Since May 16, 2018, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $0.9277 (Jun 13, 2018), with a median of $0.4254 per EA.

Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of QUETIAPINE ER 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures QUETIAPINE ER 400 MG TABLET?

QUETIAPINE ER 400 MG TABLET (NDC 33342013709) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.